Literature DB >> 30502339

Quantitative proteomics reveals distinct composition of amyloid plaques in Alzheimer's disease.

Feng Xiong1, Wei Ge2, Chao Ma3.   

Abstract

INTRODUCTION: We investigated the proteomic profiles of amyloid plaques (APs) from Alzheimer's disease (AD) and age-matched non-AD brains and APP/PS1 transgenic model mice.
METHODS: APs and adjacent control regions were collected from fresh-frozen brain sections using laser capture dissection. Proteins were quantitated using tag-labeling coupled high-throughput mass spectra.
RESULTS: Over 4000 proteins were accurately quantified, and more than 40 were identified as highly enriched in both AD and non-AD APs, including apoE, midkine, VGFR1, and complement C4. Intriguingly, proteins including synaptic structural proteins and complement C1r, C5, and C9 were found to be upregulated in AD APs but not non-AD APs. Moreover, the proteomic pattern of AD APs was distinct from APP/PS1 APs and exhibited correlation with aging hippocampus. DISCUSSION: Our results provide new insight into AP composition. We demonstrate unexpected differences between AD, non-AD, and APP/PS1 mouse APs, which may relate to different pathological processes.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  Alzheimer's disease; Amyloid plaque; Laser dissection; Proteomics

Mesh:

Substances:

Year:  2019        PMID: 30502339     DOI: 10.1016/j.jalz.2018.10.006

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  23 in total

1.  Progress in Human Brain Banking in China.

Authors:  Chao Ma; Ai-Min Bao; Xiao-Xin Yan; Dick F Swaab
Journal:  Neurosci Bull       Date:  2019-03-07       Impact factor: 5.203

2.  Deep Multilayer Brain Proteomics Identifies Molecular Networks in Alzheimer's Disease Progression.

Authors:  Bing Bai; Xusheng Wang; Yuxin Li; Ping-Chung Chen; Kaiwen Yu; Kaushik Kumar Dey; Jay M Yarbro; Xian Han; Brianna M Lutz; Shuquan Rao; Yun Jiao; Jeffrey M Sifford; Jonghee Han; Minghui Wang; Haiyan Tan; Timothy I Shaw; Ji-Hoon Cho; Suiping Zhou; Hong Wang; Mingming Niu; Ariana Mancieri; Kaitlynn A Messler; Xiaojun Sun; Zhiping Wu; Vishwajeeth Pagala; Anthony A High; Wenjian Bi; Hui Zhang; Hongbo Chi; Vahram Haroutunian; Bin Zhang; Thomas G Beach; Gang Yu; Junmin Peng
Journal:  Neuron       Date:  2020-01-08       Impact factor: 17.173

3.  Aβ Plaques.

Authors:  Lary C Walker
Journal:  Free Neuropathol       Date:  2020-10-30

4.  Heterotypic Amyloid β interactions facilitate amyloid assembly and modify amyloid structure.

Authors:  Katerina Konstantoulea; Patricia Guerreiro; Meine Ramakers; Nikolaos Louros; Liam D Aubrey; Bert Houben; Emiel Michiels; Matthias De Vleeschouwer; Yulia Lampi; Luís F Ribeiro; Joris de Wit; Wei-Feng Xue; Joost Schymkowitz; Frederic Rousseau
Journal:  EMBO J       Date:  2021-11-29       Impact factor: 11.598

Review 5.  Harnessing endophenotypes and network medicine for Alzheimer's drug repurposing.

Authors:  Jiansong Fang; Andrew A Pieper; Ruth Nussinov; Garam Lee; Lynn Bekris; James B Leverenz; Jeffrey Cummings; Feixiong Cheng
Journal:  Med Res Rev       Date:  2020-07-13       Impact factor: 12.944

Review 6.  Cerebral amyloid angiopathy and Alzheimer disease - one peptide, two pathways.

Authors:  Steven M Greenberg; Brian J Bacskai; Mar Hernandez-Guillamon; Jeremy Pruzin; Reisa Sperling; Susanne J van Veluw
Journal:  Nat Rev Neurol       Date:  2019-12-11       Impact factor: 42.937

7.  APOE immunotherapy reduces cerebral amyloid angiopathy and amyloid plaques while improving cerebrovascular function.

Authors:  Monica Xiong; Hong Jiang; Javier Remolina Serrano; Ernesto R Gonzales; Chao Wang; Maud Gratuze; Rosa Hoyle; Nga Bien-Ly; Adam P Silverman; Patrick M Sullivan; Ryan J Watts; Jason D Ulrich; Gregory J Zipfel; David M Holtzman
Journal:  Sci Transl Med       Date:  2021-02-17       Impact factor: 17.956

8.  Pulse-Chase Proteomics of the App Knockin Mouse Models of Alzheimer's Disease Reveals that Synaptic Dysfunction Originates in Presynaptic Terminals.

Authors:  Timothy J Hark; Nalini R Rao; Charlotte Castillon; Tamara Basta; Samuel Smukowski; Huan Bao; Arun Upadhyay; Ewa Bomba-Warczak; Toshihiro Nomura; Eileen T O'Toole; Garry P Morgan; Laith Ali; Takashi Saito; Christelle Guillermier; Takaomi C Saido; Matthew L Steinhauser; Michael H B Stowell; Edwin R Chapman; Anis Contractor; Jeffrey N Savas
Journal:  Cell Syst       Date:  2020-12-15       Impact factor: 10.304

9.  Platelet biomarkers for a descending cognitive function: A proteomic approach.

Authors:  Haitao Yu; Yanchao Liu; Benrong He; Ting He; Chongyang Chen; Jiahua He; Xifei Yang; Jian-Zhi Wang
Journal:  Aging Cell       Date:  2021-05-04       Impact factor: 9.304

10.  The Altered Anatomical Distribution of ACE2 in the Brain With Alzheimer's Disease Pathology.

Authors:  Huan Cui; Si Su; Yan Cao; Chao Ma; Wenying Qiu
Journal:  Front Cell Dev Biol       Date:  2021-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.